Recruiting
Phase 2

Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer

Sponsor:

Centre hospitalier de l'Université de Montréal (CHUM)

Code:

NCT04178174

Conditions

Head and Neck Cancer

Oropharynx Cancer

Human Papilloma Virus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SABR boost and de-escalated chemoradiation

Standard chemoradiation

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information